Prime Medicine Inc

Research Prime Medicine Inc (PRME) on Bullrun: market cap USD 671.90M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPRME
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 671.90M
• Financial periodFY2025
• RevenueUSD 4.63M
• Revenue growth55.3%
• Net income-USD 201.14M
• Free cash flow-USD 167.10M

Valuation Snapshot

latest market cap is USD 671.90M.

About Prime Medicine Inc

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate is PM359 for Chronic Granulomatous Disease, which is in Phase 1/2 clinical trial; PM577 for Wilson Disease, that is in preclinical studies;

Frequently asked questions

What is Prime Medicine Inc's market cap?

Prime Medicine Inc's market capitalization is USD 671.90M.

What does Prime Medicine Inc do?

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.